nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant therapy in lymphnode positive prostate cancer
|
Schmeller, N. |
|
1998 |
37 |
2 |
p. 141-144 |
artikel |
2 |
Adjuvant therapy in lymphnode positive prostate cancer
|
Schmeller, N. |
|
1998 |
37 |
2 |
p. 141-144 |
artikel |
3 |
Antiandrogen with drawal syndrome
|
Breul, J. |
|
1998 |
37 |
2 |
p. 156-158 |
artikel |
4 |
Antiandrogen with drawal syndrome
|
Breul, J. |
|
1998 |
37 |
2 |
p. 156-158 |
artikel |
5 |
BlasenkarzinomTeil 2: Harnableitung
|
Lampel, A. |
|
1998 |
37 |
2 |
p. 207-220 |
artikel |
6 |
BlasenkarzinomTeil 2: Harnableitung
|
Lampel, A. |
|
1998 |
37 |
2 |
p. 207-220 |
artikel |
7 |
Complete androgen blockade versus monotherapie
|
Altwein, J. E. |
|
1998 |
37 |
2 |
p. 149-152 |
artikel |
8 |
Complete androgen blockade versus monotherapie
|
Altwein, J. E. |
|
1998 |
37 |
2 |
p. 149-152 |
artikel |
9 |
Development of tumor selection on the basis of pathological staging in clinically localized prostate carcinoma
|
Noldus, J. |
|
1998 |
37 |
2 |
p. 195-198 |
artikel |
10 |
Development of tumor selection on the basis of pathological staging in clinically localized prostate carcinoma
|
Noldus, J. |
|
1998 |
37 |
2 |
p. 195-198 |
artikel |
11 |
Die Bedeutung des prostataspezifischen Antigens in der Nachsorge beim Prostatakarzinom
|
Hertle, L. |
|
1998 |
37 |
2 |
p. 170-171 |
artikel |
12 |
Die Bedeutung des prostataspezifischen Antigens in der Nachsorge beim Prostatakarzinom
|
Hertle, L. |
|
1998 |
37 |
2 |
p. 170-171 |
artikel |
13 |
Fundamentals and principles of tissue transfer
|
Jordan, G. H. |
|
1998 |
37 |
2 |
p. 180-194 |
artikel |
14 |
Fundamentals and principles of tissue transfer
|
Jordan, G. H. |
|
1998 |
37 |
2 |
p. 180-194 |
artikel |
15 |
Indication for nuclear medicine therapy in advanced cancer of the prostate
|
Schoeneich, G. |
|
1998 |
37 |
2 |
p. 162-166 |
artikel |
16 |
Indication for nuclear medicine therapy in advanced cancer of the prostate
|
Schoeneich, G. |
|
1998 |
37 |
2 |
p. 162-166 |
artikel |
17 |
Intermittent versus continuous androgen blockage
|
Wolff, J. M. |
|
1998 |
37 |
2 |
p. 153-155 |
artikel |
18 |
Intermittent versus continuous androgen blockage
|
Wolff, J. M. |
|
1998 |
37 |
2 |
p. 153-155 |
artikel |
19 |
Is gene therapy soon going to be used clinically in advanced cancer of the prostate?
|
Gschwend, J. E. |
|
1998 |
37 |
2 |
p. 172-174 |
artikel |
20 |
Is gene therapy soon going to be used clinically in advanced cancer of the prostate?
|
Gschwend, J. E. |
|
1998 |
37 |
2 |
p. 172-174 |
artikel |
21 |
Leitlinien urologischer Betreuung Querschnittgelähmter
|
|
|
1998 |
37 |
2 |
p. 221-228 |
artikel |
22 |
Leitlinien urologischer Betreuung Querschnittgelähmter
|
, |
|
1998 |
37 |
2 |
p. 221-228 |
artikel |
23 |
Pain therapy and quality of life
|
Harzmann, R. |
|
1998 |
37 |
2 |
p. 167-169 |
artikel |
24 |
Pain therapy and quality of life
|
Harzmann, R. |
|
1998 |
37 |
2 |
p. 167-169 |
artikel |
25 |
Rekonstruktion von Meatus/Fossa navicularis unter Verwendung von Hautlappentechnik
|
Jordan, G. H. |
|
1998 |
37 |
2 |
p. 175-179 |
artikel |
26 |
Rekonstruktion von Meatus/Fossa navicularis unter Verwendung von Hautlappentechnik
|
Jordan, G. H. |
|
1998 |
37 |
2 |
p. 175-179 |
artikel |
27 |
Therapy of hormonerefractory cancer of the prostate
|
Bex, A. |
|
1998 |
37 |
2 |
p. 159-161 |
artikel |
28 |
Therapy of hormonerefractory cancer of the prostate
|
Bex, A. |
|
1998 |
37 |
2 |
p. 159-161 |
artikel |
29 |
The VATER-syndrom – patients in urology
|
Werner, W. |
|
1998 |
37 |
2 |
p. 203-205 |
artikel |
30 |
The VATER-syndrom – patients in urology
|
Werner, W. |
|
1998 |
37 |
2 |
p. 203-205 |
artikel |
31 |
Transforming growth factor-β1 (TGF-β1) levels in plasma of patients with prostate cancer and benign prostatic hyperplasia (BPH)
|
Lange, I. |
|
1998 |
37 |
2 |
p. 199-202 |
artikel |
32 |
Transforming growth factor-β1 (TGF-β1) levels in plasma of patients with prostate cancer and benign prostatic hyperplasia (BPH)
|
Lange, I. |
|
1998 |
37 |
2 |
p. 199-202 |
artikel |
33 |
Treatment of progressive, local, advanced cancer of the prostate
|
Niesel, T. |
|
1998 |
37 |
2 |
p. 145-148 |
artikel |
34 |
Treatment of progressive, local, advanced cancer of the prostate
|
Niesel, T. |
|
1998 |
37 |
2 |
p. 145-148 |
artikel |
35 |
Wann ist mit einer Androgendeprivation zu beginnen?
|
Bex, A. |
|
1998 |
37 |
2 |
p. 133-134 |
artikel |
36 |
Wann ist mit einer Androgendeprivation zu beginnen?
|
Bex, A. |
|
1998 |
37 |
2 |
p. 133-134 |
artikel |
37 |
What importance does radical prostatectomy have in lymph node-positive cancer of the prostate?
|
Huland, H. |
|
1998 |
37 |
2 |
p. 138-140 |
artikel |
38 |
What importance does radical prostatectomy have in lymph node-positive cancer of the prostate?
|
Huland, H. |
|
1998 |
37 |
2 |
p. 138-140 |
artikel |
39 |
What is to be done if the margin of resection is positive after radical prostatectomy?
|
Wirth, M. |
|
1998 |
37 |
2 |
p. 135-137 |
artikel |
40 |
What is to be done if the margin of resection is positive after radical prostatectomy?
|
Wirth, M. |
|
1998 |
37 |
2 |
p. 135-137 |
artikel |